News & Events

News

All categories

Earnings

Press Release

All years

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Announces Addition to NASDAQ Biotechnology Index

December 18, 2019

Affimed Reports Third Quarter 2019 Financial Results and Recent Operational Progress

November 19, 2019

Affimed to Present at the Jefferies 2019 London Healthcare Conference

November 14, 2019

Affimed Announces Third Quarter 2019 Financial Results and Corporate Update Conference Call on November 19, 2019

November 14, 2019

Affimed Announces Closing of Public Offering of Common Shares and Exercise of Underwriters’ Option to Purchase Additional Shares

November 13, 2019

Affimed Announces Pricing of Public Offering of Common Shares

November 8, 2019

Affimed Announces Proposed Public Offering of Common Shares

November 7, 2019

Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Expressing Cancers

November 7, 2019

Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech

November 7, 2019

Affimed Reports Progress on Key Clinical Development Programs

October 15, 2019

Events

All

Scientific

Investors

02Nov

PEGS Europe

November 2 - 4, 2021 (Barcelona, Spain)

10Nov

SITC 2021

November 10 - 14, 2021 (Washington, D.C. (and virtual))

Webcasts
More events